Befuraline
- Level
- Commodity
- Parent
- 51294400
- Below
- 0
- Links · KBLI
- 8
Definition
UNSPSC 51294404This classification denotes a phosphodiesterase inhibitor and antidepressant agent, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 787AQ35GHR. European Medicines Agency schedules Befuraline in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05683MIG. Befuraline generally arises in the molecular formula C20H20N2O2. The term BEFURALINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 30, no. 10 1976, list 16.) BEFURALINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule befuraline under HS 29349990 and SITC 51579. As of Q4 2014, BEFURALINE remains the US FDA Preferred Term for this commodity. Befuraline bears US NLM identifiers UMLS ID C0053072 and NCI Concept Code C72720. SMILES: o1c(C(=O)N2CCN(CC2)Cc2ccccc2)cc2c1cccc2.
Same parent
Under 51294400 · 23Activities that produce or sell this
KBLI · 8Inherited from family 51290000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.